Published in Exp Diabetes Res on May 28, 2012
Regulation of glucose homeostasis by GLP-1. Prog Mol Biol Transl Sci (2014) 0.97
Effects of glucagon-like peptide-1 receptor agonists on renal function. World J Diabetes (2013) 0.89
Sitagliptin use and thyroid cancer risk in patients with type 2 diabetes. Oncotarget (2016) 0.84
Impaired glucose metabolism treatment and carcinogenesis. Oncol Lett (2015) 0.77
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet (2009) 9.32
Diabetes and cancer: a consensus report. Diabetes Care (2010) 6.71
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest (1993) 5.06
Diabetes and cancer. Endocr Relat Cancer (2009) 5.04
Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology (2011) 4.99
Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration. J Med Chem (2000) 3.29
The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men. Diabetologia (2002) 2.97
Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab (2006) 2.81
Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest (1987) 2.70
Safety and tolerability of pioglitazone in high-risk patients with type 2 diabetes: an overview of data from PROactive. Drug Saf (2009) 2.67
Mortality and causes of death in a national sample of diabetic patients in Taiwan. Diabetes Care (2004) 2.56
Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation. Endocrinology (2010) 2.33
Pioglitazone and bladder cancer: a population-based study of Taiwanese. Diabetes Care (2011) 2.00
Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus. Am J Health Syst Pharm (2005) 1.96
Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia (2006) 1.93
Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy. N Engl J Med (2010) 1.91
Glucagon like peptide-1 receptor expression in the human thyroid gland. J Clin Endocrinol Metab (2011) 1.83
Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab (2004) 1.82
Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan. Diabetologia (2011) 1.59
Diabetes and risk of prostate cancer: a study using the National Health Insurance. Diabetes Care (2011) 1.47
Papillary thyroid carcinoma. Endocrinol Metab Clin North Am (1990) 1.45
Incretin-based therapies in type 2 diabetes mellitus. J Clin Endocrinol Metab (2008) 1.45
GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide. J Clin Endocrinol Metab (2011) 1.40
Structure-activity and protraction relationship of long-acting glucagon-like peptide-1 derivatives: importance of fatty acid length, polarity, and bulkiness. J Med Chem (2007) 1.26
Age-related risk of mortality from bladder cancer in diabetic patients: a 12-year follow-up of a national cohort in Taiwan. Ann Med (2009) 1.23
Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006. Diabetologia (2008) 1.18
Diabetes and non-Hodgkin's lymphoma: analyses of prevalence and annual incidence in 2005 using the National Health Insurance database in Taiwan. Ann Oncol (2011) 1.11
Exendin-4, but not glucagon-like peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigs. Diabetologia (2006) 1.10
Diabetes conveys a higher risk of gastric cancer mortality despite an age-standardised decreasing trend in the general population in Taiwan. Gut (2010) 1.02
Effects of glucagon and glucagon-like peptide-1-(7-36) amide on C cells from rat thyroid and medullary thyroid carcinoma CA-77 cell line. Endocrinology (1996) 0.98
Expression of glucagon-like peptide 1 receptor in a murine C cell line: regulation of calcitonin gene by glucagon-like peptide 1. FEBS Lett (1996) 0.98
Prostate cancer mortality in Taiwanese men: increasing age-standardized trend in general population and increased risk in diabetic men. Ann Med (2011) 0.95
GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation. Endocrinology (2012) 0.91
Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer. Endocr Relat Cancer (2009) 0.82
Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ Health Perspect (2012) 2.05
The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese. Exp Diabetes Res (2012) 1.53
Continuity of care, medication adherence, and health care outcomes among patients with newly diagnosed type 2 diabetes: a longitudinal analysis. Med Care (2013) 1.31
Arsenic and diabetes and hypertension in human populations: a review. Toxicol Appl Pharmacol (2007) 1.31
Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis (2011) 1.24
Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan. Toxicol Appl Pharmacol (2006) 1.21
Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan. Environ Health Perspect (2003) 1.17
Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour. J Pathol (2015) 1.14
Disabled-2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells. FEBS Lett (2003) 1.13
Evidence for improved control of hypertension in Taiwan: 1993-2002. J Hypertens (2008) 1.11
Diabetes and thyroid cancer risk: literature review. Exp Diabetes Res (2012) 1.02
Gender differences in trends in diabetes prevalence from 1993 to 2008 in Taiwan. Diabetes Res Clin Pract (2010) 0.98
Uric acid concentration as a risk marker for blood pressure progression and incident hypertension: a Chinese cohort study. Metabolism (2012) 0.97
Metabolic syndrome components worsen lower urinary tract symptoms in women with type 2 diabetes. J Clin Endocrinol Metab (2010) 0.96
Measurement of Waist Circumference: midabdominal or iliac crest? Diabetes Care (2012) 0.94
Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia. Clin Chim Acta (2009) 0.92
Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes. Diabetes (2011) 0.91
Bioactivity-guided screening identifies pheophytin a as a potent anti-hepatitis C virus compound from Lonicera hypoglauca Miq. Biochem Biophys Res Commun (2009) 0.90
Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy. Surgery (2011) 0.89
Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease. Clin Biochem (2008) 0.89
Ovarian cancer-related hypophosphatemic osteomalacia--a case report. J Clin Endocrinol Metab (2014) 0.87
Metabolic syndrome defined by IDF and AHA/NHLBI correlates better to carotid intima-media thickness than that defined by NCEP ATP III and WHO. Diabetes Res Clin Pract (2009) 0.85
Does medication adherence lead to lower healthcare expenses for patients with diabetes? Am J Manag Care (2013) 0.85
Quantitative analysis of multidrug-resistance mdr1 gene expression in head and neck cancer by real-time RT-PCR. Jpn J Cancer Res (2002) 0.85
Haemoglobin A1c is associated with carotid intima-media thickness in a Chinese population. Clin Endocrinol (Oxf) (2011) 0.85
The performance of risk scores and hemoglobin A1c to find undiagnosed diabetes with isolated postload hyperglycemia. Endocr J (2011) 0.84
Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chinese type 2 diabetic patients. Acta Diabetol (2008) 0.84
Global impacts of geogenic arsenic: a medical geology research case. Ambio (2007) 0.83
Arsenic exposure and diabetes mellitus in the United States. JAMA (2008) 0.82
Diabetes and cancer: epidemiological, clinical, and experimental perspectives. Exp Diabetes Res (2012) 0.81
Serum C-reactive protein levels correlates better to metabolic syndrome defined by International Diabetes Federation than by NCEP ATP III in men. Diabetes Res Clin Pract (2007) 0.80
Betel nut chewing is independently associated with urinary albumin excretion rate in type 2 diabetic patients. Diabetes Care (2006) 0.80
Thyroid segmentation and volume estimation in ultrasound images. IEEE Trans Biomed Eng (2010) 0.80
Postprandial blood glucose is associated with generalized pruritus in patients with type 2 diabetes. Eur J Dermatol (2013) 0.79
A population study on the association between leisure time physical activity and self-rated health among diabetics in Taiwan. BMC Public Health (2010) 0.78
Relapse of acute myeloid leukemia at the pituitary gland: a case report and review of literature. Endocr Pathol (2012) 0.78
Genetic variation in the carbonyl reductase 3 gene confers risk of type 2 diabetes and insulin resistance: a potential regulator of adipogenesis. J Mol Med (Berl) (2012) 0.78
Incidence of type 1 diabetes mellitus in children aged 0-14 years during 1992-1996 in Taiwan. Acta Paediatr (2008) 0.77
Apolipoprotein B is an independent risk factor for microalbuminuria in Taiwanese patients with type 2 diabetes. Diabetes Care (2003) 0.77
Prevalence and risk factors of diabetic foot problems in Taiwan: a cross-sectional survey of non-type 1 diabetic patients from a nationally representative sample. Diabetes Care (2003) 0.77
Serum vascular adhesion protein-1 level is higher in smokers than non-smokers. Ann Hum Biol (2013) 0.76
Pitfalls in the study using death certificates to demonstrate the reversibility of mortality from diabetes in the blackfoot disease endemic areas in Taiwan. J Occup Environ Med (2006) 0.75
Resistance Training Improves Muscle Function and Cardiometabolic Risks But Not Quality of Life in Older People With Type 2 Diabetes Mellitus: A Randomized Controlled Trial. J Geriatr Phys Ther (2016) 0.75
Reactive plasmacytosis of the thyroid gland in a patient with disseminated tuberculosis. Acta Cytol (2005) 0.75
Aging and current perception threshold measured by neurometer in normal Taiwanese adults. J Am Geriatr Soc (2002) 0.75
Combination of frequency and amplitude-modulated model for the synthesis of normal and wheezing sounds. Australas Phys Eng Sci Med (2011) 0.75
Asymmetric intense bilateral adrenal uptake on [18F]fluorodeoxyglucose positron emission tomography/computed tomography in a patient with solitary pulmonary nodule. J Clin Oncol (2012) 0.75
The age- and sex-specific incidence and medical expenses of heart failure hospitalization in 2005 in Taiwan: a study using data from the National Health Insurance. J Am Geriatr Soc (2010) 0.75